10393 San Diego Mission Rd, Suite 120
San Diego, CA 92108-2134
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
(Courtesy of Wikimedia Commons. Public domain.)
Neuro-Ophthalmology & Neuro-Otology
Oct. 21, 2020
Mar. 04, 2021
Inadequate sleep hygiene entails the behaviors, practices, rituals, and habits that result in sleep onset or maintenance difficulties and unrefreshing
Jul. 13, 2021
Neuroacanthocytosis is a neurologic syndrome characterized by a broad spectrum of movement disorders that often share acanthocytes on the blood smear. A variety of other neurologic symptoms may accompany neuroacanthocytosis, including seizures, motor neuron disease, and dementia. Chorea-acanthocytosis is an autosomal recessive disorder due to mutations in the VPS13A gene (chromosome 9q21), and is among the disorders known to cause neuroacanthocytosis.
Dec. 04, 2020
Childhood Degenerative & Metabolic Disorders
Sep. 06, 2020
Stroke & Vascular Disorders
Fibromuscular dysplasia is a relatively uncommon multifocal arterial disease of unknown cause, characterized by nonatherosclerotic abnormalities involving the smooth muscle, fibrous and elastic tissue, of small- to medium-sized arterial walls. Cerebrovascular lesions may include arterial dissection and aneurysms. The most common neurologic symptoms are nonspecific, including headaches, vertigo, pulsatile tinnitus, sudden hearing loss, altered mentation, neck pain, and syncope.
Dec. 02, 2020
Neuropharmacology & Neurotherapeutics
This article discusses pyridostigmine, the most commonly used first-line therapy for myasthenia gravis. The article addresses the pharmacology, indications, contraindications, treatment goals, dosing, special considerations, interactions, and adverse effects to be considered in the use of this cholinesterase inhibitor.
Mar. 12, 2021
Dysarthria is defined as difficulty in articulation of words due to neurologic disturbances of function of orofacial muscles, tongue, lips, and throat. Dysarthria can be due to a range of causes that include lesions in the cortical motor-face area, cerebellum, cranial nerves innervating muscles of articulation, and local lesions of the structures involved in articulation of speech. Clinical manifestation depends on the cause of dysarthria and associated diseases.
Mar. 28, 2021